Endocrine sequelae are common in cancer survivors. Incidence and prevalence rates over time remain difficult to interpret because of small study sizes and variable treatment regimens. Nevertheless, patients at risk of developing endocrinologic sequelae can be identified and followed carefully so that treatment, when necessary, is provided in a timely manner and morbidity is minimized or prevented.
|Original language||English (US)|
|Number of pages||21|
|Journal||Endocrinology and Metabolism Clinics of North America|
|State||Published - Sep 2005|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism